Evolva (EVE)

Business description

Evolva is a Swiss high-tech fermentation company. It has a proprietary yeast technology platform, which it uses to create and manufacture high-value speciality molecules for nutritional and consumer products.

Stock data

Market cap.CHF236.6m
Last closeCHF0.31
High / Low (52 weeks)CHF0.6 / CHF0.3
Stock market listingSW
Forecast net cash (CHFm)99.4
Forecast gearing ratio (%)N/A
SectorFood & Drink

Price performance

Relative *(9.4)0.8(39.4)

* % Relative to local index

Other companies in sector Show

Company news

Evolva Holding SA

Thu, 20 Apr 2017 04:52:30 GMT

Evolva to Acquire Allylix

Tue, 18 Nov 2014 06:01:29 GMT

What's Next for EVOLVA HOLDING (OTCMKTS:ELVAF) After Having More Shares Shorted?

Mon, 12 Feb 2018 11:03:45 GMT

BRIEF-Evolva announces major restructuring for next phase of its development‍​

Wed, 30 Aug 2017 06:00:00 GMT

Evolva & Cargill Announce Publication Of Stevia Reb M Patent Application

Fri, 15 Aug 2014 05:01:33 GMT

Y/E Dec Revenue (CHFm) EBITDA (CHFm) PBT (CHFm) EPS (CHFc) P/E (x) P/CF (x)
2015A 13.4 (30.3) (32.1) (7.0) N/A N/A
2016A 9.5 (34.0) (36.0) (6.9) N/A N/A
2017E 7.4 (29.8) (30.9) (5.5) N/A N/A
2018E 11.3 (28.7) (28.9) (3.7) N/A N/A

Last updated on 24/01/2018

Latest research

Capital restructuring

Update | Food & Drink | 05/01/2018

Transformation evolving

Update | Food & Drink | 17/08/2017

Agreement reached

Outlook | Food & Drink | 09/05/2017

Headroom improves

Update | Food & Drink | 16/03/2017

A cloudier picture

Update | Food & Drink | 16/01/2017

On track

Update | Food & Drink | 01/09/2016

Positive stevia newsflow

Update | Food & Drink | 07/06/2016

Stevia delayed

Update | Food & Drink | 06/04/2016

Tastes good

Outlook | Food & Drink | 15/01/2016

Getting sweeter

QuickView | Food & Drink | 19/11/2015

Rights issue supports stevia JV

Update | Food & Drink | 07/09/2015

Manufacturing a sweeter future

Update | Pharmaceutical & healthcare | 18/05/2015

Investment summary

Evolva has an innovative fermentation platform focused on developing new production methods for nutritional and consumer health products, which removes supply chain issues for existing natural ingredients. Evolva's key programme for stevia sweeteners is partnered with Cargill and we expect launch during 2018. Evolva also has projects for resveratrol, nootkatone, valencene (all on the market). Evolva is currently consolidating its sites, concentrating R&D at its Swiss HQ and its Lexington (US) site, and reducing overall headcount from c 180 to c 100, significantly lowering its operating expenses. A CHF21m private placement occurred in October and a CHF65m rights issue was completed in November, giving Evolva a net cash balance of over CHF100m.

Last updated on 02/02/2018

Industry outlook

Food and health ingredients continue to be in the sweet spot as consumers demand healthier products with cleaner labels without compromising on taste or convenience. Evolva's fermentation platform aims to deliver these benefits while reducing production costs.

Last updated on 02/02/2018

Key management

Gerard Hoetmer, Chairman
Simon Waddington, CEO
Oliver Walker, CFO

Company address

Duggingerstrasse. 23
+41 61 485 2000
View website